At EAU 2025, Dr. Marco Moschini addresses the debate on the required extent of TURBT for muscle-invasive bladder cancer (MIBC). He explains that the surgical approach depends on the patient’s treatment plan. Transcript Interviewer Welcome everybody to the EAU 25...
At EAU 2025, Dr. Alexandra Masson-Lecomte, a leading expert on the urothelial cancer guidelines, addresses the complex question of how to manage synchronous upper and lower tract urothelial cancer. Focusing on patients with high-grade urothelial cancer, she details a...
Marie-Pier St-Laurent from Vancouver, urologic oncologist, and David Anderer, an urologist from Vienna, Austria, discussed the role of ctDNA in urothelial cancer research. Dr. St-Laurent explained that ctDNA can be used in tumor-informed or tumor-naive approaches,...
